NCT05571527View on ClinicalTrials.gov

Comparison of Vaginal Hyaluronic Acid Treatment Over Autologous Platelet Rich Plasma Treatment for Genitourinary Syndrome of Menopause

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

December 1, 2024

Conditions
Genitourinary Syndrome of Menopause
Interventions
BIOLOGICAL

Platelet Rich Plasma treatment

Patients receive platelet-rich plasma via injection into the vaginal area.

DRUG

Vaginal Hyaluronic Acid supplement

Patients receive Vaginal Hyaluronic Acid supplement for 10 days, then once a week for 3 months.

Trial Locations (1)

34307

RECRUITING

Kanuni Sultan Suleyman Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Kanuni Sultan Suleyman Training and Research Hospital

OTHER